Oncoginase 6000Iu Injection
1 Injection(s) in InjectionMRP ₹825.00
₹618.75
25% OFF
Made by
CHANDRA BHAGAT PHARMA PRIVATE LIMITED
Dosage
INJECTION
Expiry
Product Summary
| Uses | Acute lymphoblastic leukemia, Lymphoblastic lymphoma |
| Therapy | Anti-neoplastic |
| Side effects | Nausea, Allergic reactions, High blood sugar, Fever, Fatigue |
Assurance
available
Regulated
Medical Description
Oncoginase is an injectable medicine used in the treatment of certain types of leukemia and lymphoma. It works by interfering with the growth of abnormal blood cells at the molecular level.
Uses
- Acute lymphoblastic leukemia
- Lymphoblastic lymphoma
Contraindications
Side effects
- Nausea
- Allergic reactions
- High blood sugar
- Fever
- Fatigue
Precautions and Warnings
Pregnancy
Breast Feeding
Alcohol
Driving
Other General Warnings
- You experience severe abdominal pain, nausea, and vomiting.
- You notice sudden swelling, pain, or redness in your arms or legs, or severe headaches, vision changes, confusion, or seizures.
- You develop signs of an allergic reaction, such as rash, wheezing, or low blood pressure during or after administration.
- You experience extreme thirst, frequent urination, or confusion, which may indicate high blood sugar.
- You develop unusual bleeding or bruising, as Oncoginase injection can affect blood clotting.
- You have liver problems or develop yellowing of the skin or eyes, dark urine, or severe weakness.
Directions for Use
Storage and disposal
Quick Tips
- Attend all scheduled treatment appointments
- Report any allergic reactions or unusual symptoms immediately
- Keep regular blood tests scheduled to monitor treatment effects
- Maintain good nutrition during treatment
- Ask your doctor about managing side effects
Dosage
Overdose
Missed a Dose
How does this medicine work?
Interactions
Interactions with other medicines
Interactions with food items
Frequently Asked Questions (FAQs)
References:
- Health Products Regulatory Authority (HPRA). Crisantaspase (Erwinase) powder for solution for injection/infusion: summary of product characteristics (SmPC) [Internet]. Dublin: HPRA; 2026 May [cited 2026 Aug 28].
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; [cited 2026 Aug 28].
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:ONCOGINASE
Vendor Details
Fulfillment Information: Oncoginase Injection (1) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
